Whole Pelvic Radiation May Improve Survival in Advanced Cervical Cancer
Treating women with stage IVB cervical cancer with whole pelvic radiation along with standard chemotherapy improved survival over chemotherapy alone in a retrospective study.
SLN Biopsy Alone Can Reduce Surgical Morbidity in Early Cervical Cancer
The use of sentinel lymph node biopsy alone in women with early cervical cancer resulted in less surgical morbidity without a significant increase in the risk of recurrence, according to a new prospective study.
Two Doses of HPV Vaccine Optimal, Third Dose Adds No Benefit
Women who receive two doses of HPV vaccine have higher prophylactic efficacy than women who receive only one dose, according to a database study.
Treatment Disparities in Locally Advanced Cervical Cancer Impact Survival
In this interview we discuss a recent study that found that more than half of patients with locally advanced cervical cancer in the United States did not receive standard of care.
Burden of Breast, Cervical Cancer Falls Mostly to Low-, Middle-Income Countries
A new paper highlights the global inequities in access to prevention, early detection and treatment for breast cancer and cervical cancer.
Nab-Paclitaxel/Nedaplatin Combination Promising in Advanced Cervical Cancer
The combination of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) and nedaplatin showed promising activity and was relatively well tolerated in a small phase II trial.
HPV Vaccination Leads to Decreased Rates of Cervical Pre-Cancers
The human papillomavirus (HPV) vaccine reduces the incidence of pre-cancerous cervical intraepithelial neoplasia (CIN), according to a population-based study in New Mexico.
By clicking Accept, you agree to become a member of the UBM Medica Community.